| Completed randomized clinical trials |
Randomized phase III trial of AP (doxorubicin + cisplatin) therapy, DP (docetaxel + cisplatin) therapy, and TC (paclitaxel + carboplatin) therapy as adjuvant chemotherapy for endometrial cancer at a high risk of recurrence |
JGOG2043 |
Endometrial Cancer |
UMIN000000522 |
| Randomized phase III trial of conventional paclitaxel and carboplatin versus dose dense weekly paclitaxel and carboplatin in patients with newly diagnosed stage II-IV Mullerian carcinoma (ovarian epithelial, primary peritoneal, or fallopian tube cancer) |
JGOG3016 |
Ovarian Cancer |
C000000183 |
| Randomized phase III trial of paclitaxel plus carboplatin (TC) therapy versus irinotecan plus cisplatin (CPT-P) therapy as a first line chemotherapy for clear cell carcinoma of the ovary |
GCIG/JGOG3017 |
Ovarian Cancer |
UMIN000000499 |
| A randomized phase II/III trial of intravenous (IV) paclitaxel weekly plus IV carboplatin once every 3 weeks versus IV paclitaxel weekly plus intraperitoneal (IP) carboplatin once every 3 weeks in women with epithelial ovarian, fallopian tube or primary peritoneal cancer |
GOTIC/JGOG3019 |
Ovarian Cancer |
UMIN000003670/NCT01506856 |
| Ongoing trials/studies |
Adjuvant chemotherapy versus radiotherapy for postoperative cervical cancer; a phase III trial |
JGOG1082 |
Cervical Cancer |
jRCTs041190042 |
| Clinicopathological study on glassy cell carcinoma of the cervix |
JGOG1086S |
Cervical Cancer |
UMIN000050237 |
| A non-randomized confirmatory trial of minimum invasive laparoscopic radical hysterectomy (new-Japanese LRH) for patients with early-stage cervical cancer |
JGOG1087 |
Cervical Cancer |
UMIN000045224 |
| Phase II trial of repeated high dose luteal hormone therapy for intrauterine recurrence following fertility preserving therapy for atypical endometrial hyperplasia or endometrial cancer |
JGOG2051 |
Endometrial Cancer |
jRCT031200256 |
| Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency |
JGOG2052 |
Uterine Leiomyosarcoma and Others |
jRCT2031210264 |
| Phase III trial of stage I ovarian cancer after surgery |
JGOG3020 |
Ovarian Cancer |
jRCTs031180423/NCT04063527 |
| Prospective cohort study of germline variant carriers with BRCA1 or BRCA2 |
JGOG3024 |
Ovarian Cancer |
UMIN000028740/NCT03296826 |
| Assessment of the efficacy and safety of pembrolizumab for ovarian squamous cell carcinoma |
JGOG3029 |
Ovarian Cancer |
jRCT2031220701 |
| An observational study to investigate the safety and efficacy of olaparib combined with bevacizumab therapy after primary chemotherapy plus bevacizumab for Japanese patients with advanced ovarian, fallopian tube, or primary peritoneal cancer |
JGOG3030 |
Ovarian Cancer |
UMIN000047107 |
| An observational study to investigate the safety and efficacy of niraparib for Japanese patients with recurrent ovarian cancer: maintenance therapy for platinum-sensitive recurrent treatment and monotherapy for late-line treatment |
JGOG3031 |
Ovarian Cancer |
UMIN000046970 |
